Institution · Moorgreen Hospital
Most cited papers from Moorgreen Hospital
What are the most cited papers from Moorgreen Hospital?
The most cited paper from Moorgreen Hospital is "Neuroinflammation in Alzheimer's disease" (Michael Thomas Heneka et al., 2015), with 6,318 citations. Next come "Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial" (1,406) and "Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report" (1,404).
Showing 50 of 60 papers. Every paper with more than 89 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Neuroinflammation in Alzheimer's disease Michael Thomas Heneka et al. · The Lancet Neurology | 16 Mar 2015 | 6,318 |
| 2 | Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial Clive Holmes, Delphine Boche, David G. Wilkinson et al. · The Lancet | Jul 2008 | 1,406 |
| 3 | Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report James A. R. Nicoll, David G. Wilkinson, Clive Holmes et al. · Nature Medicine | 17 Mar 2003 | 1,404 |
| 4 | Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study Ian Grant McKeith, John Tiernan O'Brien, Zuzana Walker et al. · The Lancet Neurology | 28 Feb 2007 | 720 |
| 5 | Periodontitis and Cognitive Decline in Alzheimer’s Disease Mark Ide, Marina Harris, Annette Stevens et al. · PLoS ONE | 10 Mar 2016 | 470 |
| 6 | General practice consultations: is there any point in being positive? Karen Thomas · BMJ | 9 May 1987 | 427 |
| 7 | Review: Systemic inflammation and A lzheimer's disease Clive Holmes · Neuropathology and Applied Neurobiology | 10 Oct 2012 | 373 |
| 8 | Cholinesterase Inhibitors Used in the Treatment of Alzheimer???s Disease David G. Wilkinson, Paul T. Francis, Elias M. Schwam et al. · Drugs & Aging | 2004 | 367 |
| 9 | Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies Clive Holmes, Nigel J. Cairns, Peter L Lantos et al. · The British Journal of Psychiatry | 1999 | 364 |
| 10 | Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD Antony J. Bayer, R. Morris Bullock, Roy W. Jones et al. · Neurology | 11 Jan 2005 | 355 |
| 11 | Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease Clive Holmes · Journal of Neurology Neurosurgery & Psychiatry | 16 May 2003 | 330 |
| 12 | Consequence of Aβ immunization on the vasculature of human Alzheimer's disease brain Delphine Boche, E. Zotova, Roy O. Weller et al. · Brain | 25 Oct 2008 | 314 |
| 13 | Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial Philip Scheltens, Patrick J G H Kamphuis, Frans R.J. Verhey et al. · Alzheimer s & Dementia | 2010 | 302 |
| 14 | Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial Kenneth J. Rockwood · Journal of Neurology Neurosurgery & Psychiatry | Nov 2001 | 285 |
| 15 | Inflammatory components in human Alzheimer’s disease and after active amyloid-β42 immunization Elina Zotova, Viraj Bharambe, Matthew Cheaveau et al. · Brain | 13 Aug 2013 | 279 |
| 16 | Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy Elina Zotova, James A. R. Nicoll, Raj N. Kalaria et al. · Alzheimer s Research & Therapy | 2010 | 270 |
| 17 | Etanercept in Alzheimer disease Joseph Butchart, Laura Brook, Vivienne Hopkins et al. · Neurology | May 2015 | 252 |
| 18 | Proinflammatory cytokines, sickness behavior, and Alzheimer disease Clive Holmes, Colm M. Cunningham, E. Zotova et al. · Neurology | 14 Jul 2011 | 247 |
| 19 | Galantamine: a randomized, double‐blind, dose comparison in patients with Alzheimer's disease David G. Wilkinson, Jane L. Murray · International Journal of Geriatric Psychiatry | Sep 2001 | 215 |
| 20 | Lavender oil as a treatment for agitated behaviour in severe dementia: a placebo controlled study Clive Holmes, Vivienne Hopkins, Christine Hensford et al. · International Journal of Geriatric Psychiatry | Apr 2002 | 203 |
| 21 | Oral acyclovir in acute herpes zoster. M.W. McKendrick, James I McGill, John White et al. · BMJ | 13 Dec 1986 | 203 |
| 22 | Diabetes in the UK: 2019 Clare Alexandra Whicher, Simon O’Neill, Richard I. G. Holt · Diabetic Medicine | 4 Jan 2020 | 202 |
| 23 | Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer’s disease James A. R. Nicoll, George R. Buckland, Charlotte H. Harrison et al. · Brain | 9 May 2019 | 197 |
| 24 | Reality Orientation and Reminiscence Therapy S. Sucunza Baines, Peter John Saxby, Karen Ehlert · The British Journal of Psychiatry | Aug 1987 | 190 |
| 25 | EFNS guideline on diagnosis and management of post‐polio syndrome. Report of an EFNS task force Erlend Hoftun Farbu, Nils Erik Gilhus, Michael Paul Barnes et al. · European Journal of Neurology | 12 Jun 2006 | 181 |
| 26 | Determining the minimum clinically important differences for outcomes in the DOMINO trial Robert Howard et al. · International Journal of Geriatric Psychiatry | 16 Sep 2010 | 179 |
| 27 | Delusions associated with elevated muscarinic binding in dementia with Lewy bodies Clive G. Ballard, Margaret Ann Piggott, Mary Johnson et al. · Annals of Neurology | Dec 2000 | 165 |
| 28 | Safety and efficacy of idalopirdine, a 5-HT 6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial David G. Wilkinson, Kristian Windfeld, Eskild Colding‐Jørgensen · The Lancet Neurology | 5 Oct 2014 | 163 |
| 29 | A MULTINATIONAL, RANDOMISED, 12‐WEEK, COMPARATIVE STUDY OF DONEPEZIL AND RIVASTIGMINE IN PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE D. G. Wilkinson, AP Passmore, R. Morris Bullock et al. · International Journal of Clinical Practice | Jul 2002 | 160 |
| 30 | Enhanced Relief of Phobias by Flooding During Waning Diazepam Effect I. M. Marks, Ramachandran Viswanathan, M S Lipsedge et al. · The British Journal of Psychiatry | Nov 1972 | 159 |
| 31 | Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial Ian Grant McKeith, Janet Grace, Zuzana Walker et al. · International Journal of Geriatric Psychiatry | May 2000 | 152 |
| 32 | Donepezil in Vascular Dementia: Combined Analysis of Two Large-Scale Clinical Trials Gustavo C. Román, David G. Wilkinson, Rachelle Smith Doody et al. · Dementia and Geriatric Cognitive Disorders | 2005 | 141 |
| 33 | Enabling more dying people to remain at home. Graham Thorpe · BMJ | 9 Oct 1993 | 138 |
| 34 | Neuropathology after active Aβ42 immunotherapy: implications for Alzheimer’s disease pathogenesis Delphine Boche, Nathan C. Denham, Clive Holmes et al. · Acta Neuropathologica | 14 Jul 2010 | 134 |
| 35 | The safety and tolerability of donepezil in patients with Alzheimer's disease Stephen Jackson, Richard J. Ham, David G. Wilkinson · British Journal of Clinical Pharmacology | 20 Oct 2004 | 133 |
| 36 | An evaluation of the mental health impact of SARS-CoV-2 on patients, general public and healthcare professionals: A systematic review and meta-analysis Peter Phiri, Rema Ramakrishnan, Shanaya Rathod et al. · EClinicalMedicine | Apr 2021 | 129 |
| 37 | Non‐attendance at diabetes outpatient appointments: a systematic review Sarah Brewster, Jazz Bartholomew, Richard I. G. Holt et al. · Diabetic Medicine | 22 Jan 2020 | 129 |
| 38 | Control of defecation in patients with spinal injuries by stimulation of sacral anterior nerve roots. Riodrach MacDonagh, Weiming Sun, Rod H Smallwood et al. · BMJ | 9 Jun 1990 | 127 |
| 39 | Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy Alireza Atri, José Luís Molinuevo, Ole Michael Lemming et al. · Alzheimer s Research & Therapy | 21 Jan 2013 | 126 |
| 40 | Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success? Bengt Winblad, Henry Brodaty, Serge Gauthier et al. · International Journal of Geriatric Psychiatry | Jul 2001 | 126 |
| 41 | The Locus Coeruleus in Aging and Alzheimer’s Disease: A Postmortem and Brain Imaging Review Rebecca Beardmore, Ruihua H. Hou, Angela Darekar et al. · Journal of Alzheimer s Disease | 3 Jul 2021 | 122 |
| 42 | Lack of effect of acyclovir on postherpetic neuralgia. M.W. McKendrick, James I McGill, Marsha Wood · BMJ | 18 Feb 1989 | 118 |
| 43 | PATHOLOGICAL OSSIFICATION IN TRAUMATIC PARAPLEGIA A G Hardy, John W. Dickson · Journal of Bone and Joint Surgery - British Volume | Feb 1963 | 115 |
| 44 | Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic Helen P. Matthews, Jane Korbey, David G. Wilkinson et al. · International Journal of Geriatric Psychiatry | 2000 | 112 |
| 45 | Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation Clive Holmes · Journal of Neurology Neurosurgery & Psychiatry | Dec 2001 | 112 |
| 46 | Seasonal and Weather Factors in Parasuicide Andrew Paul Barker, Keith E Hawton, Joan Fagg et al. · The British Journal of Psychiatry | Sep 1994 | 111 |
| 47 | The nature and efficacy of culturally-adapted psychosocial interventions for schizophrenia: a systematic review and meta-analysis Amy Degnan, Sophie Baker, Dawn Edge et al. · Psychological Medicine | 23 Aug 2017 | 110 |
| 48 | Double-blind randomized phase II study of hyperbaric oxygen in patients with radiation-induced brachial plexopathy Joyce Pritchard, Praveen Anand, J. A. Broome et al. · Radiotherapy and Oncology | Mar 2001 | 109 |
| 49 | Microglial alterations in human Alzheimer's disease following Aβ42 immunization E. Zotova, Clive Holmes, David Annandale Johnston et al. · Neuropathology and Applied Neurobiology | 17 Dec 2010 | 107 |
| 50 | PROTECTIVE EFFECT OF 1-ADAMANTANAMINE HYDROCHLORIDE ON INFLUENZA A2 INFECTIONS IN THE FAMILY ENVIRONMENT A. W. Galbraith, J. S. Oxford, G. C. Schild et al. · The Lancet | Nov 1969 | 107 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.